Review
Reappraisal of the risk/benefit of nitrofurantoin: review of toxicity and efficacy
Affiliations
- PMID: 2694823
Item in Clipboard
Review
Reappraisal of the risk/benefit of nitrofurantoin: review of toxicity and efficacy
Adverse Drug React Acute Poisoning Rev.
1989 Winter.
No abstract available
Similar articles
-
Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children.J Urol. 2004 Aug;172(2):448-53. doi: 10.1097/01.ju.0000130653.74548.d6. J Urol. 2004. PMID: 15247700 Review.
-
[The place of nitrofurantoin today].Dtsch Med Wochenschr. 1983 Sep 2;108(35):1330-3. Dtsch Med Wochenschr. 1983. PMID: 6309496 Review. German. No abstract available.
-
[Gastrointestinal tolerance towards a new macrocrystaline form of furadentin: a collaborative study of 264 patients].Rev Venez Urol. 1969 Jan-Jun;21(1):101-10. Rev Venez Urol. 1969. PMID: 5356419 Spanish. No abstract available.
-
[Hypersensitivity of lungs against nitrofurantoin].Helv Med Acta Suppl. 1970 Jun:Suppl 50:131. Helv Med Acta Suppl. 1970. PMID: 5288602 German. No abstract available.
-
Nitrofurantoin.Med Lett Drugs Ther. 1971 Nov 26;13(24):99-100. Med Lett Drugs Ther. 1971. PMID: 5163864 No abstract available.
Cited by
-
Urinary tract infections in adult general practice patients.Br J Gen Pract. 2002 Sep;52(482):752-61. Br J Gen Pract. 2002. PMID: 12236281 Free PMC article. Review.
-
Non-surgical management of recurrent urinary tract infections in women.Transl Androl Urol. 2017 Jul;6(Suppl 2):S142-S152. doi: 10.21037/tau.2017.06.09. Transl Androl Urol. 2017. PMID: 28791233 Free PMC article. Review.
-
Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis.Int Urogynecol J Pelvic Floor Dysfunct. 2009 Aug;20(8):933-8. doi: 10.1007/s00192-009-0885-y. Epub 2009 Apr 10. Int Urogynecol J Pelvic Floor Dysfunct. 2009. PMID: 19582384
-
Isolation of nitrofurantoin-resistant mutants of nitroreductase-producing Clostridium sp. strains from the human intestinal tract.Antimicrob Agents Chemother. 1998 May;42(5):1121-6. doi: 10.1128/AAC.42.5.1121. Antimicrob Agents Chemother. 1998. PMID: 9593138 Free PMC article.
-
Variation in Mutant Prevention Concentrations.Front Microbiol. 2019 Jan 31;10:42. doi: 10.3389/fmicb.2019.00042. eCollection 2019. Front Microbiol. 2019. PMID: 30766517 Free PMC article.